Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Revenue: 2009-2025

Historic Revenue for Aytu Biopharma (AYTU) over the last 17 years, with Jun 2025 value amounting to $66.4 million.

  • Aytu Biopharma's Revenue fell 16.21% to $13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.7 million, marking a year-over-year decrease of 0.38%. This contributed to the annual value of $66.4 million for FY2025, which is 1.84% up from last year.
  • Aytu Biopharma's Revenue amounted to $66.4 million in FY2025, which was up 1.84% from $65.2 million recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Revenue registered a high of $107.4 million during FY2023, and its lowest value of $65.2 million during FY2024.
  • In the last 3 years, Aytu Biopharma's Revenue had a median value of $66.4 million in 2025 and averaged $79.7 million.
  • Per our database at Business Quant, Aytu Biopharma's Revenue soared by 137.52% in 2021 and then tumbled by 39.31% in 2024.
  • Yearly analysis of 5 years shows Aytu Biopharma's Revenue stood at $65.6 million in 2021, then soared by 47.29% to $96.7 million in 2022, then increased by 11.10% to $107.4 million in 2023, then slumped by 39.31% to $65.2 million in 2024, then increased by 1.84% to $66.4 million in 2025.